About EBSA20 Conference - Madrid

EBSA20 Conference - Madrid

Wednesday, 26 April 2017

17:30 - 19:00 Registration, welcome reception and opening exhibition

Thursday, 27 April 2017

08:45
Opening
Gijsbert van Willigen, EBSA President 2016
09:00
Welcome
Virginia Gálvez Perez, Directora de Departamento de Higiene, CNNT-INSHT, Spain
 
Iñaki Echeverria Machado, Spanish Biosafety Association (AEBioS), President
9:15
Biosafety Issues of Integrative Viral Gene Therapy
Dr. Guillermo Güenechea, Head of Gene Therapy Safety Unit, Hematopoietic Innovative Therapies, CIEMAT/CIBERER/IIS-FJD, Spain
 
Guidance for movement of biological materials for use in R&D
Astrid Coppens, Ablynx, Belgian Biosafety Professional task force
10:00
Coffee break
 
Parallel session 1 Biosafety in hospital settings
10:30
Clinical care of Hemorrhagic fevers in Madrid: our two years learning curve
Dr. Marta Mora-Rillo, Hospital Universitario La Paz-Carlos III
11:00
High Isolation Level Unit and Biosafety at the Defence Central Hospital "Gómez Ulla"
Dr. Patricia Obregon, Head of Biosafety HILU, High Level Isolation Unit and Biosafety at the Defense Central Hospital “Gómez Ulla”, Spain
 
Mycobacterium chimaera infections linked to cardiac surgery - what are the risks and how to do you prevent exposure?
Jimmy Walker, Scientific Lead for Water and Decontamination, Public Health England
 
Parallel session 2 Biosafety and vector organisms
10:30
Working with arthropods at a BSL3: to be bitten or not to be bitten
Xavier Abad, IRTA-CReSA, Centre de Recerca en Sanitat Animal - Animal Health Research Center (Cataluña Autonomous Community)
11:00
Biosafety recommendations for One-health parasites
Dr. Muhammad Imran RASHID, Assistant Professor, Department of Parasitology,
University of Veterinary and Animal Sciences, Lahore, Pakistan
11:30
Horizontal gene transfer of antibiotic resistance genes to native waste water flora
Dr. Claudia Bagutti, Gesundheitsdepartement des Kantons Basel-Stadt, Switzerland
12:00
Lunch + exhibition
13:00
Poster presentations and Commercial presentations
 
ACTINI SAS
 
Grupo Albian
 
Controlling and reducing risk with a new generation of membrane filtration technology
AAF International
 
Understanding the Math of Thermal Treatment - a Practical Discussion
PriBio
14:00
Chris Collins Lecture
WHO GAP III roadmap to compliance for poliovirus-essential facilities
Toon De Kesel, Biorisk Expert, Febris, Belgium
15:00
Coffee break + exhibition
 
Session 3 Ethics of biosafety
15:30
Quality vs Biorisk management: and the winner is…?
Franca Rizzo, Anses-Nancy Laboratory for Rabies and Wildlife, France
16:00
Assessment the efficiency of disinfectants used in decontamination activities in CLEVB
Nermin Hodhod, Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Egypt
16:30
The Many Components of Strengthening National Biorisk Systems Around the Globe
Natalie DeGraaf, U.S. Centers for Disease Control - Division of Select Agents and Toxins, United States of America
17:00
Annual General Meeting of EBSA
19:30
Conference dinner